In stock · depth page
BPC-157 / TB-500 — COA and identity (RUO)
Blend identity · HPLC area percent · mass-spec
BPC-157 10 mg + TB-500 10 mg blend · COA note
For laboratory research use only. Not for human or veterinary use, consumption, compounding into a medicine, or injection. Not authorized by Health Canada. Literature on this page is scientific context only. This page is not a licensed drug, a wellness protocol, or a dosing guide.
Match names, registry numbers when listed, strength, lot, HPLC area percent, and mass before the cake is reconstituted.
What to match before bench release
Pass criteria: BPC-157 and TB-500 / thymosin β4 language on the COA matches the purchase order and the vial; CAS 137525-51-0 and CAS 77591-33-4 when the certificate lists them; strength is the 10 mg + 10 mg blend; the COA lot equals the sealed vial lot; HPLC area percent is reported under a stated method, including a note when components are reported separately; observed mass or m/z is consistent with the expected peptides; the analysis date is recorded against ship and receipt; the storage statement aligns with the laboratory SOP and the COA.
Log the vial label. Archive the lot-matched PDF with the invoice number. Quarantine the vial if component names, purity, or mass disagree with the request record. Streuli et al. (2026) and the 2020 AAPS PharmSciTech paper are method context. They do not replace the lot COA.
Identity
Form
Lyophilized blend, sealed vial
Strength
10 mg + 10 mg lyophilized blend
Purity
HPLC area percent on the lot COA
CAS
- BPC-157: 137525-51-0
- Thymosin β4 / TB-500: 77591-33-4
PubMed
Selected literature
- PMID 41667417 (2026) Streuli et al., Journal of Peptide Science — HPLC/FPLC analysis transferability
- PMID 31953771 (2020) Walsh et al., AAPS PharmSciTech — variance when preparing analytical standards for lyophilized peptide chromatography
Literature is scientific context only. A paper does not make a research vial into a licensed medicine.
Bench reconstitution
Identity and purity checks come before reconstitution. Dissolve the blend cake only after component names, HPLC, and mass agree with the receiving record.
Diluent page: bacteriostatic water.
Storage
Keep the lyophilized vial at 2–8 °C, protected from light and moisture, until the bench protocol calls for it. After reconstitution, hold at 2–8 °C; use within the sterility window your laboratory controls allow. Do not freeze–thaw repeatedly. Record open date and concentration in the notebook. Confirm the lot COA before you adopt a hold time.
Certificate of analysis
Every product has a View COA button. Where the lot certificate of analysis (identity and HPLC purity) is posted, it opens the certificate with a PDF download. Where it is not posted yet, the same button sends a request by email to request@pharmapeptidesrx.com, or you can write that address with the SKU. This page is not a COA.
Lab FAQ
Is an HPLC area-percent figure a clinical-grade claim?
No. It is an analytical attribute under the stated method for research-use-only material. Write request@pharmapeptidesrx.com and ask for the lot-matched COA on the blend. This page does not publish prices or banking details. Invoices go out from request@ only.
In this library
In stock · list price
Request from the catalog
Every vial on the catalog shows its CAD list price. Add it to your request and we email the invoice. Labs pay by Interac e-Transfer. No card checkout.